Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Study of Ceftazidime-Avibactam to Characterize the Usage in Clinical Practice

NCT05487586 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05487586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Study of Ceftazidime-Avibactam to Characterize the Usage in Clinical Practice
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
October 20, 2022
Completion date
July 11, 2024
Enrollment
220 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

complicated intra abdominal infections, hospital acquired pneumonia, ventilator acquired pneumonia